HHS Awards $22.4M for EPI Task Force Support to Eagle Health Analytics, LLC

Contract Overview

Contract Amount: $22,420,669 ($22.4M)

Contractor: Eagle Health Analytics, LLC

Awarding Agency: Department of Health and Human Services

Start Date: 2022-08-10

End Date: 2026-01-31

Contract Duration: 1,270 days

Daily Burn Rate: $17.7K/day

Competition Type: NOT AVAILABLE FOR COMPETITION

Number of Offers Received: 1

Pricing Type: LABOR HOURS

Sector: R&D

Official Description: EPI TASK FORCE SUPPORT

Place of Performance

Location: ATLANTA, DEKALB County, GEORGIA, 30329

State: Georgia Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $22.4 million to EAGLE HEALTH ANALYTICS, LLC for work described as: EPI TASK FORCE SUPPORT Key points: 1. Contract awarded on a sole-source basis, limiting price competition. 2. Performance period extends over three years, indicating a need for sustained support. 3. The contract type is 'LABOR HOURS', suggesting payment based on personnel time. 4. The North American Industry Classification System (NAICS) code 541715 points to R&D in physical, engineering, and life sciences. 5. The contract is a definitive contract, typically used for complex or long-term requirements. 6. The award was made by the Centers for Disease Control and Prevention (CDC).

Value Assessment

Rating: questionable

Benchmarking the value of this contract is challenging due to the 'NOT AVAILABLE FOR COMPETITION' status and lack of detailed performance metrics. Without competitive bids, it's difficult to ascertain if the pricing reflects fair market value. The contract's duration and scope suggest a significant investment, but the absence of comparative data makes a definitive value assessment difficult. Further analysis would require understanding the specific deliverables and comparing them to similar sole-source R&D support contracts.

Cost Per Unit: N/A

Competition Analysis

Competition Level: sole-source

This contract was awarded on a sole-source basis, meaning it was not competed. This typically occurs when only one responsible source is available or when a compelling justification for other than full and open competition exists. The lack of competition means that potential alternative providers were not considered, which can limit price discovery and potentially lead to higher costs for the government.

Taxpayer Impact: Sole-source awards can result in higher costs for taxpayers as the government does not benefit from the competitive pressure that typically drives down prices.

Public Impact

The primary beneficiary is the Department of Health and Human Services, specifically the CDC, which will receive support for its EPI TASK FORCE. The services delivered are related to Research and Development in the Physical, Engineering, and Life Sciences. The geographic impact is primarily within Georgia, where the contract is managed. Workforce implications may include the direct employment of personnel by EAGLE HEALTH ANALYTICS, LLC to fulfill the contract requirements.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Lack of competition raises concerns about potential overpricing and reduced value for taxpayer money.
Sole-source awards can limit innovation by not engaging a broader range of potential contractors.
The extended performance period requires careful monitoring to ensure continued relevance and effectiveness of services.

Positive Signals

The award to a single, presumably qualified, vendor suggests a focused approach to a specific need.
The definitive contract type indicates a structured agreement for a defined scope of work.
The contract supports critical R&D activities within the CDC, potentially leading to advancements in public health.

Sector Analysis

This contract falls within the Research and Development (R&D) sector, specifically focusing on physical, engineering, and life sciences. The R&D sector is characterized by innovation and specialized expertise. The market size for such services can be substantial, driven by government funding for scientific advancement and public health initiatives. This contract represents a specific allocation of resources within the broader federal R&D spending landscape, supporting the CDC's mission.

Small Business Impact

The data indicates that this contract was not set aside for small businesses (ss: false, sb: false). Therefore, there are no direct subcontracting implications for small businesses stemming from a small business set-aside. The prime contractor, EAGLE HEALTH ANALYTICS, LLC, is responsible for its own workforce and resource management. The absence of a small business set-aside means that larger, established firms were eligible to bid, and the focus was not on promoting small business participation through this specific award.

Oversight & Accountability

Oversight for this contract would primarily reside with the Department of Health and Human Services and the Centers for Disease Control and Prevention. As a definitive contract, it is expected to have defined milestones and reporting requirements. Transparency would be enhanced by public contract databases, but detailed performance reviews and Inspector General involvement would depend on specific triggers or audits. Accountability measures are typically embedded within the contract terms and conditions.

Related Government Programs

Public Health Research and Development
Epidemiology Support Services
Life Sciences Research Contracts
Federal R&D Spending
CDC Task Orders

Risk Flags

Sole-source award may limit competition and potentially increase costs.
Lack of detailed performance metrics in summary data hinders value assessment.
Contract duration requires ongoing monitoring for continued relevance and effectiveness.

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $22.4 million to EAGLE HEALTH ANALYTICS, LLC. EPI TASK FORCE SUPPORT

Who is the contractor on this award?

The obligated recipient is EAGLE HEALTH ANALYTICS, LLC.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Centers for Disease Control and Prevention).

What is the total obligated amount?

The obligated amount is $22.4 million.

What is the period of performance?

Start: 2022-08-10. End: 2026-01-31.

What is the track record of EAGLE HEALTH ANALYTICS, LLC with federal contracts, particularly with the CDC?

Information regarding the specific track record of EAGLE HEALTH ANALYTICS, LLC with federal contracts, especially with the Centers for Disease Control and Prevention (CDC), is not detailed in the provided data. A comprehensive assessment would require reviewing past performance evaluations, contract history, and any reported issues or successes. Without this historical data, it is difficult to gauge their reliability and past performance in delivering similar services. Further investigation into federal procurement databases and past performance reviews would be necessary to establish a detailed understanding of their track record.

How does the awarded amount compare to similar R&D support contracts at the CDC or other federal agencies?

Comparing the $22.4 million award for EPI TASK FORCE SUPPORT to similar R&D support contracts is challenging without more specific details on the scope of work and deliverables. However, given the sole-source nature of this award, direct price comparisons are inherently limited. Typically, competitive bids allow for benchmarking against market rates. For R&D services, costs can vary significantly based on the scientific discipline, required expertise, and project complexity. To provide a meaningful comparison, one would need to identify other sole-source or competitively awarded contracts for comparable R&D services within the life sciences sector at agencies like the CDC or NIH, analyzing their duration, total value, and specific objectives.

What are the primary risks associated with a sole-source award for R&D support?

The primary risks associated with a sole-source award for R&D support include potential overpricing due to the lack of competitive pressure, which can lead to reduced value for taxpayer money. There's also a risk of complacency from the contractor, as there's no immediate threat of losing the contract to a competitor. Furthermore, sole-source awards may limit the government's access to a wider range of innovative solutions or specialized expertise that could be available in a competitive bidding process. Ensuring robust oversight and clear performance metrics becomes even more critical to mitigate these risks and ensure the government receives the best possible outcome.

What is the expected effectiveness of the services provided under this contract for the EPI TASK FORCE?

The expected effectiveness of the services provided under this contract for the EPI TASK FORCE hinges on the specific objectives and deliverables outlined in the contract, which are not fully detailed in the provided summary. As the contract is for R&D support in physical, engineering, and life sciences, its effectiveness will likely be measured by the quality of research, data analysis, and scientific insights generated. Successful outcomes could contribute to advancements in disease prevention, response strategies, or public health interventions. The CDC's internal program management and evaluation metrics will be crucial in assessing whether the contractor meets its performance expectations and contributes meaningfully to the EPI TASK FORCE's mission.

What are the historical spending patterns for EPI TASK FORCE SUPPORT or similar services at the CDC?

Historical spending patterns for EPI TASK FORCE SUPPORT or similar services at the CDC are not provided in the current data. To analyze this, one would need to access historical contract databases to identify previous awards for similar services, including the number of contracts, their values, durations, and the contractors involved. Understanding past spending trends can help contextualize the current $22.4 million award, revealing whether this represents an increase or decrease in investment in such support, and whether the CDC has historically relied on sole-source or competitive procurements for these types of services.

What are the specific deliverables and performance metrics for EAGLE HEALTH ANALYTICS, LLC under this contract?

The specific deliverables and performance metrics for EAGLE HEALTH ANALYTICS, LLC under this contract are not detailed in the provided summary. Typically, definitive contracts include detailed statements of work (SOW) outlining required tasks, expected outcomes, and measurable performance standards. For R&D support, these might include research reports, data analysis, scientific publications, or technical consultations. The CDC's program office would be responsible for monitoring adherence to these metrics and evaluating the contractor's performance against them. Without access to the SOW, a precise assessment of expected outcomes and effectiveness is not possible.

Industry Classification

NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Product/Service Code: SUPPORT SVCS (PROF, ADMIN, MGMT) › PROFESSIONAL SERVICES

Competition & Pricing

Extent Competed: NOT AVAILABLE FOR COMPETITION

Solicitation Procedures: ONLY ONE SOURCE

Solicitation ID: 75D301-22-R-72345

Offers Received: 1

Pricing Type: LABOR HOURS (Z)

Evaluated Preference: NONE

Contractor Details

Address: 111 W 16TH AVE, ANCHORAGE, AK, 99501

Business Categories: 8(a) Program Participant, Alaskan Native Corporation Owned Firm, Category Business, Corporate Entity Not Tax Exempt, Limited Liability Corporation, Minority Owned Business, Native American Owned Business, Self-Certified Small Disadvantaged Business, Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $22,435,669

Exercised Options: $22,435,669

Current Obligation: $22,420,669

Actual Outlays: $21,153,706

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: YES

Timeline